Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Long-Term Deferred Tax: 2018-2025

Historic Long-Term Deferred Tax for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to $2.4 million.

  • Autolus Therapeutics' Long-Term Deferred Tax fell 29.51% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 29.51%. This contributed to the annual value of $3.2 million for FY2024, which is 5.75% up from last year.
  • According to the latest figures from Q3 2025, Autolus Therapeutics' Long-Term Deferred Tax is $2.4 million, which was down 0.54% from $2.4 million recorded in Q2 2025.
  • Autolus Therapeutics' 5-year Long-Term Deferred Tax high stood at $3.4 million for Q3 2024, and its period low was $1.4 million during Q3 2021.
  • Over the past 3 years, Autolus Therapeutics' median Long-Term Deferred Tax value was $2.8 million (recorded in 2025), while the average stood at $2.8 million.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first skyrocketed by 396.10% in 2021, then fell by 29.51% in 2025.
  • Over the past 5 years, Autolus Therapeutics' Long-Term Deferred Tax (Quarterly) stood at $1.8 million in 2021, then climbed by 13.69% to $2.1 million in 2022, then spiked by 47.54% to $3.1 million in 2023, then grew by 5.75% to $3.2 million in 2024, then dropped by 29.51% to $2.4 million in 2025.
  • Its Long-Term Deferred Tax stands at $2.4 million for Q3 2025, versus $2.4 million for Q2 2025 and $2.8 million for Q1 2025.